Company intelligence / Profile preview

InnoVein

San Carlos, California, United Statespt.linkedin.com ↗

Ownership: Private
Employees: ~2
Development stage: Preclinical

Overview

InnoVein has developed an implantable prosthetic valve designed to replace poorly functioning venous valves in the legs. The technology aims to provide a definitive cure for advanced vein disease—a condition affecting over 10% of the U.S. population—by addressing pain, swelling, and blood backflow that current treatments only manage palliatively. As of recent reports, the company has raised $6.7M and continues product development; no pivotal clinical trial results or regulatory approvals have been announced publicly.

Therapeutic areas: Cardiovascular
Modalities: Device (implantable prosthetic valve)
Industry: Implantable Medical Devices

Partnerships

Y Combinator (accelerator/investor)

Beyond the preview

Go deeper on InnoVein.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InnoVein.

Explore the full profile